| BIOLOGIC | Organism | Human |
|---|---|---|
| Tissue | Liver | |
| Age | Adult | |
| Gender | Female | |
| Ethnicity | Caucasian | |
| Disease | Liver tumor of a patient suffering from cholangiocarcinoma and hepatitis C infestion | |
| PRODUCT INFORMATION | Cell Type | HepaRGTM |
| Morphology | Biliary Epithelial like cells | |
| Culture and growth properties | Already differentiated, ready-to-use | |
| Passage n° at the time of cryopreservation | Between Passage 13 and 20 | |
| Cells per vial | Minimum 8×106 cells | |
| Viability | ≥80% after thawing | |
| Sterility test | Negative for Bacterial, Mycoplasma, Yeast | |
| Serology test | Negative for hepatitis B, hepatitis C and HIV1 viruses | |
| Product Format | Cryopreserved 1ml vial | |
| Dedicated Applications | Applications covered : Metabolism, Transporters, Infectious diseases, Bioartificial liver, 3D |
CRYOPRESERVED HEPARG 116 CELLS
HepaRG cells are cryopreserved after differentiation using a proprietary process developed by Biopredic International. Few days after thawing and culture, the cells will form a coculture of fully differentiated hepatocytes and biliary epithelial-like cells.
5 in stock
